C12N 2310/126
Involving rnase p
Official title: involving RNAse P
C12N2310/126 (Involving rnase p) appears on 70 US grants and 26 published applications in this corpus.
Search patents in C12N- Granted patents
- 70
- Published applications
- 26
- Assignees
- 17
- Inventors
- 62
- Latest grant
- 25 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 16 | 0 |
| 1998 | 13 | 0 |
| 1999 | 9 | 0 |
| 2000 | 7 | 0 |
| 2001 | 2 | 0 |
| 2002 | 8 | 4 |
| 2003 | 4 | 7 |
| 2004 | 1 | 1 |
| 2005 | 1 | 2 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 2 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 2 | 1 |
| 2024 | 0 | 2 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- RNA cleavage-induced transcript stabilizer and uses thereof25 Nov 2025US 12,480,119 B2Massachusetts Institute of Technology
- RNA cleavage-induced transcript stabilizer and uses thereof24 Oct 2023US 11,795,455 B2Massachusetts Institute of Technology
- Regulation of gene expression by aptamer-modulated RNase p cleavage29 Aug 2023US 11,739,333 B2Meiragtx UK II Limited
- Oral delivery of nucleic acid-based gene interfering agents by Salmonella19 Jul 2016US 9,394,541 B2The Regents of the University of California
- Oral delivery of nucleic acid-based gene interfering agents by Salmonella30 Dec 2014US 8,921,335 B2The Regents of the University of California
- Rna cleavage-induced transcript stabilizer and uses thereof18 Apr 2024US 2024/0124877 A1Massachusetts Institute of Technology
- Regulation of gene expression by aptamer-modulated rnase p cleavage4 Jan 2024US 2024/0002862 A1Meiragtx UK II Limited
- Compositions and methods of treatment for lytic and lysogenic viruses16 Feb 2023US 2023/0048681 A1Excision Biotherapeutics, Inc.
- Compositions and methods of treatment for lytic and lysogenic viruses26 Mar 2020US 2020/0095586 A1Excision Biotherapeutics, Inc.
- Regulation of gene expression by aptamer-modulated rnase p cleavage20 Feb 2020US 2020/0056182 A1
Most cited
By later US patents
- 2'deoxy-2'-alkylnucleotide containing nucleic acid521US 5,627,053 ARibozyme Pharmaceuticals, Inc. · 1997
- RNA polymerase III-based expression of therapeutic RNAs154US 5,902,880 ARibozyme Pharmaceuticals, Inc. · 1999
- Stabilized external guide sequences129US 6,057,153 AYale University · 2000
- Cleavage of targeted RNA by RNAase P108US 5,168,053 AYale University · 1992
- Site specific cleavage of single-stranded DNA88US 5,180,818 AUniversity of Colorado Foundation, Inc. · 1993